The global blood warmer devices market is projected to expand from USD 451.2 million in 2022 to approximately USD 937.5 million by 2032, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period.
A key driver of this market growth is the rising need for efficient blood warming solutions in medical procedures, particularly in trauma care, surgery, and intensive care settings. Blood warmer devices are critical in preventing hypothermia by rapidly warming blood and intravenous fluids, enhancing patient safety and treatment outcomes.
Among product segments, intravenous warming systems continue to dominate, accounting for about 47.1% of the market share in 2021. These systems are favored due to their effective and efficient performance in warming fluids during intravenous infusions, a critical component in both emergency and routine clinical care.
Full Report Revealed – https://www.futuremarketinsights.com/reports/blood-warmer-devices-market
Key Takeaways:
- Market Growth: Estimated to grow from $451.2 million in 2022 to ~$937.5 million by 2032 at a CAGR of 7.6%.
- Leading Product: Intravenous warming systems led the market with a 47.1% share in 2021.
- Driving Factors: Growing need for blood warming solutions in surgeries, trauma care, and intensive care settings.
- Future Trends: Increasing adoption of advanced warming systems and continuous innovation to improve patient outcomes.
The continued demand for blood warmer devices highlights their essential role in patient care, with increasing adoption across healthcare facilities set to propel further growth in the market.
Growth Drivers
- Increasing Prevalence of Hypothermia: The rising incidence of hypothermia, particularly in surgical and trauma patients, is driving demand for blood warmer devices, which are essential for maintaining normothermia during procedures.
- Technological Advancements: Innovations in blood warming technologies, including more efficient intravenous warming systems, are enhancing patient safety and comfort, leading to increased adoption.
- Growing Surgical Procedures: The high volume of surgical procedures performed globally necessitates effective blood warming solutions to prevent complications associated with cold blood transfusions.
- Awareness and Training: Increased awareness about the risks of hypothermia and training for healthcare professionals on the importance of blood warming during transfusions are contributing to market growth.
Regional Insights
- North America is expected to dominate the market due to advanced healthcare infrastructure and a high prevalence of surgical interventions.
- Other regions, such as Europe and Asia-Pacific, are also anticipated to witness significant growth driven by increasing healthcare investments and rising awareness about hypothermia management.
Competitive Landscape
To strengthen their presence around the globe and improve their business strategies, key players are involved in various product launches, expansions, collaborations, and mergers & acquisitions. Below are some of the key promotional strategies adopted by key players in the global blood warmer devices market:
- On January 6, 2022, ICU Medical Inc. announced its acquisition of Smiths Medical from Smiths Group plc.
- In March 2019, Smiths Medical announced the launch of Level 1 Convective Warmer. It is a simple thermal care product to help patients maintain their normal body temperature.
Key Companies Profiled
3M Company; Becton Dickinson (BD); The 37 Company; Emit Corporation; GE Healthcare; Stryker Corporation; Barkey GmbH & Co. KG; Geratherm Medical; Stihler Electronic GmbH; Belmont Instrument; Biegler GmbH; Baxter International Inc. (Gambro); Keewell Medical Technology Co. Ltd.; ICU Medical Inc. (Smiths Medical); Vyaire Medical, Inc.,; The Surgical Company; Life Warmer; MEQU; Estill Medical Technologies, Inc.; Smisson-Cartledge Biomedical
Key Segments Covered in Blood Warmer Devices Market Report
By Product:
- Intravenous Warming System
- Surface Warming System
- Blood Warming Accessories
By Application:
- Preoperative Care
- Home Care
- Acute Care
- New Born Care
- Others
By End User:
- Hospitals and Clinics
- Ambulatory Services
- Blood Banks
- Home Care Settings
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
